dr. brufsky discusses biosimilar development and approval
Published 6 years ago • 68 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
7:22
an overview of biosimilarity
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
9:26
the future direction of biosimilars
-
3:33
biosimilars: manufacturing and inherent variation
-
38:08
the gut brain axis: connecting microbiota and depression | premsyl bercik, md
-
4:12
the basics of biosimilars
-
5:56
the complexity of choosing biosimilars in oncology
-
1:25
dr. brufsky addresses biosimilar skepticism
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
3:38
biosimilar trastuzumab
-
0:59
dr. verma discusses biosimilars for trastuzumab
-
1:48
dr. markman on the concept of biosimilars in oncology
-
1:23
biosimilars – what they are and what you need to know.
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
8:10
module 6: biosimilars—advances in research and development
-
1:17
dr. lyman on educating physicians about biosimilars in oncology
-
8:20
pharmacovigilance requirements for biosimilar products
-
8:31
fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer
-
1:30
dr. brufsky on genomic assays for breast cancer
-
1:55
dr. kolberg on collecting real-world biosimilar trastuzumab data in breast cancer